KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Inventory (2016 - 2026)

Quest Diagnostics' Inventory history spans 18 years, with the latest figure at $225.0 million for Q1 2026.

  • On a quarterly basis, Inventory rose 19.05% to $225.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $225.0 million, a 19.05% increase, with the full-year FY2025 number at $189.0 million, up 0.53% from a year prior.
  • Inventory hit $225.0 million in Q1 2026 for Quest Diagnostics, up from $189.0 million in the prior quarter.
  • Over the last five years, Inventory for DGX hit a ceiling of $225.0 million in Q1 2026 and a floor of $181.0 million in Q1 2024.
  • Historically, Inventory has averaged $189.3 million across 5 years, with a median of $187.0 million in 2022.
  • Biggest five-year swings in Inventory: fell 11.66% in 2022 and later grew 19.05% in 2026.
  • Tracing DGX's Inventory over 5 years: stood at $192.0 million in 2022, then decreased by 1.04% to $190.0 million in 2023, then dropped by 1.05% to $188.0 million in 2024, then increased by 0.53% to $189.0 million in 2025, then grew by 19.05% to $225.0 million in 2026.
  • Business Quant data shows Inventory for DGX at $225.0 million in Q1 2026, $189.0 million in Q4 2025, and $186.0 million in Q3 2025.